A postbiotic fermented oat gruel may have a beneficial effect on the colonic mucosal barrier in patients with irritable bowel syndrome

被引:10
作者
Bednarska, Olga [1 ]
Biskou, Olga [2 ]
Israelsen, Hans [3 ]
Winberg, Martin E. [2 ]
Walter, Susanna [1 ,4 ]
Keita, Asa V. [2 ]
机构
[1] Linkoping Univ Hosp, Dept Gastroenterol, Linkoping, Sweden
[2] Linkoping Univ, Dept Biomed & Clin Sci, Linkoping, Sweden
[3] Nord Rebalance AS, Hillerod, Denmark
[4] Linkoping Univ, Dept Hlth Med & Caring Sci, Linkoping, Sweden
关键词
postbiotics; IBS-irritable bowel syndrome; intestinal barrier; fermented oats; gut permeability; LACTOBACILLUS-PLANTARUM; 299V; TIGHT JUNCTION PROTEINS; QUALITY-OF-LIFE; HOSPITAL ANXIETY; SYMPTOMS; PERMEABILITY; EFFICACY; DIARRHEA; ARTICLE; DEFENSE;
D O I
10.3389/fnut.2022.1004084
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: Impaired intestinal permeability and microbial dysbiosis are important pathophysiological mechanisms underlying irritable bowel syndrome (IBS). ReFerm (R)( ), also called Profermin (R), is a postbiotic product of oat gruel fermented with Lactobacillus plantarum 299v. In this study, we investigated whether ReFerm (R) has a beneficial effect on the intestinal epithelial barrier function in patients with IBS.Materials and methods: Thirty patients with moderate to severe IBS-diarrhoea (IBS-D) or IBS-mixed (IBS-M) were treated with enema containing ReFerm (R) or placebo. The patients underwent sigmoidoscopy with biopsies obtained from the distal colon at baseline and after 14 days of treatment with ReFerm (R) or placebo twice daily. The biopsies were mounted in Ussing chambers, and paracellular and transcellular permeabilities were measured for 120 min. In addition, the effects of ReFerm (R) or placebo on the epithelial barrier were investigated in vitro using Caco-2 cells.Results: ReFerm (R) reduced paracellular permeability (p < 0.05) and increased transepithelial resistance (TER) over time (p < 0.01), whereas the placebo had no significant effect in patients. In ReFerm (R)-treated Caco-2 cells, paracellular and transcellular permeabilities were decreased compared to the control (p < 0.05) and placebo (p < 0.01). TER was increased in Caco-2 ReFerm (R)-treated cells, and normalised TER was increased in ReFerm (R)-treated Caco-2 cells compared to control (p < 0.05) and placebo-treated (p < 0.05) cells.Conclusion: ReFerm (R) significantly reduced paracellular permeability and improved TER in colonic biopsies collected from patients with IBS and in a Caco-2 cell model. Our results offer new insights into the potential benefits of ReFerm (R) in IBS management. Further studies are needed to identify the molecular mechanisms underlying the barrier-protective properties of ReFerm (R).
引用
收藏
页数:12
相关论文
共 69 条
[11]   Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: an ex-vivo organ culture model of post-infectious irritable bowel syndrome [J].
Compare, Debora ;
Rocco, Alba ;
Coccoli, Pietro ;
Angrisani, Debora ;
Sgamato, Costantino ;
Iovine, Barbara ;
Salvatore, Umberto ;
Nardone, Gerardo .
BMC GASTROENTEROLOGY, 2017, 17
[12]   Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV [J].
Drossman, Douglas A. .
GASTROENTEROLOGY, 2016, 150 (06) :1262-+
[13]   Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome [J].
Ducrotte, Philippe ;
Sawant, Prabha ;
Jayanthi, Venkataraman .
WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (30) :4012-4018
[14]   Defence molecules in intestinal innate immunity against bacterial infections [J].
Eckmann, L .
CURRENT OPINION IN GASTROENTEROLOGY, 2005, 21 (02) :147-151
[15]   Placebo effects and their determinants in gastrointestinal disorders [J].
Elsenbruch, Sigrid ;
Enck, Paul .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2015, 12 (08) :472-485
[16]   Irritable bowel syndrome [J].
Enck, Paul ;
Aziz, Qasim ;
Barbara, Giovanni ;
Farmer, Adam D. ;
Fukudo, Shin ;
Mayer, Emeran A. ;
Niesler, Beate ;
Quigley, Eamonn M. M. ;
Rajilic-Stojanovic, Mirjana ;
Schemann, Michael ;
Schwille-Kiuntke, Juliane ;
Simren, Magnus ;
Zipfel, Stephan ;
Spiller, Robin C. .
NATURE REVIEWS DISEASE PRIMERS, 2016, 2 :1-24
[17]   The irritable bowel severity scoring system: A simple method of monitoring irritable bowel syndrome and its progress [J].
Francis, CY ;
Morris, J ;
Whorwell, PJ .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (02) :395-402
[18]   Survival of the probiotic, L-plantarum 299v and its effects on the faecal bacterial flora, with and without gastric acid inhibition [J].
Goossens, D ;
Jonkers, D ;
Russel, M ;
Thijs, A ;
van den Bogaard, A ;
Stobberingh, E ;
Stockbrügger, R .
DIGESTIVE AND LIVER DISEASE, 2005, 37 (01) :44-50
[19]   INVITRO MEASUREMENT OF GASTROINTESTINAL TISSUE PERMEABILITY USING A NEW DIFFUSION CELL [J].
GRASS, GM ;
SWEETANA, SA .
PHARMACEUTICAL RESEARCH, 1988, 5 (06) :372-376
[20]   Intestinal barrier dysfunction in irritable bowel syndrome: a systematic review [J].
Hanning, Nikita ;
Edwinson, Adam L. ;
Ceuleers, Hannah ;
Peters, Stephanie A. ;
De Man, Joris G. ;
Hassett, Leslie C. ;
De Winter, Benedicte Y. ;
Grover, Madhusudan .
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2021, 14